Deep Transformers for Computing and Predicting ALCOA+Data Integrity Compliance in the Pharmaceutical Industry

Author:

Kavasidis Isaak1,Lallas Efthimios1,Leligkou Helen C.2ORCID,Oikonomidis Georgios2,Karydas Dimitrios2,Gerogiannis Vassilis C.1ORCID,Karageorgos Anthony1ORCID

Affiliation:

1. School of Technology, University of Thessaly, 412 22 Larissa, Greece

2. Department of Industrial Design and Production Engineering, University of Western Attica, 122 43 Athens, Greece

Abstract

Strict adherence to data integrity and quality standards is crucial for the pharmaceutical industry to minimize undesired effects and ensure that medicines are of the required quality and safe for patients. A common data quality standard in the pharmaceutical industry is ALCOA+, which is a set of guiding principles for ensuring data integrity. Failure to comply with ALCOA+ guidelines, usually detected after audit inspections, may result in serious consequences for pharmaceutical manufacturers, such as the incurrence of fines, increase in costs, and production delays. It is, therefore, imperative to devise methods able to monitor ALCOA+ compliance and detect decreasing trends in data quality automatically. In this paper we present ALCOAi, a deep learning model based on the transformer architecture, which is able to process large quantities of non-homogeneous data and compute current and future ALCOA+ compliance. The proposed model can estimate trends concerning most ALCOA+ principles. The model was tested on a real dataset comprising raw sensor data, machine-provided values, and human-entered free-text data from two pharmaceutical manufacturing lines. The performed tests led to promising results in forecasting ALCOA+ compliance.

Funder

Smart Pharmaceutical Manufacturing

Publisher

MDPI AG

Subject

Fluid Flow and Transfer Processes,Computer Science Applications,Process Chemistry and Technology,General Engineering,Instrumentation,General Materials Science

Reference32 articles.

1. Digitalization in pharmaceutical industry: What to focus on under the digital implementation process?;Hole;Int. J. Pharm. X,2021

2. Data integrity within the biopharmaceutical sector in the era of Industry 4.0;Alosert;Biotechnol. J.,2022

3. An audit of pharmaceutical continuous manufacturing regulatory submissions and outcomes in the US;Fisher;Int. J. Pharm.,2022

4. McDermott, O., Antony, J., Sony, M., and Daly, S. (2022). Barriers and enablers for continuous improvement methodologies within the Irish pharmaceutical industry. Processes, 10.

5. Towards a computational approach for the assessment of compliance of ALCOA+ Principles in pharma industry;Leal;Stud. Health Technol. Inform.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3